TuHURA BIOSCIENCES, INC./NV Accounts Receivable, after Allowance for Credit Loss
TuHURA BIOSCIENCES, INC./NV (HURA) had Accounts Receivable, after Allowance for Credit Loss of $0 as of 2012-12-31, per its 10-Q filed 2013-01-18.
Discontinued › Balance Sheet › Assets
us-gaap:AccountsReceivableNet · last filed 2013-01-18
- 2012-12-31: Accounts Receivable, after Allowance for Credit Loss $0.00.
- 2012-09-30: Accounts Receivable, after Allowance for Credit Loss $0.00.
- 2012-06-30: Accounts Receivable, after Allowance for Credit Loss $0.00.
- 2012-03-31: Accounts Receivable, after Allowance for Credit Loss $0.00.
| Period end | Accounts Receivable, after Allowance for Credit Loss |
|---|---|
| 2012-12-31 | $0.00 10-Q · filed 2013-01-18 |
| 2012-09-30 | $0.00 10-Q/A · filed 2012-12-20 |
| 2012-06-30 | $0.00 10-Q · filed 2013-01-18 |
| 2012-03-31 | $0.00 10-Q/A · filed 2012-06-05 |
| 2011-12-31 | $0.00 10-Q · filed 2012-02-07 |
| 2011-06-30 | $5.00K 10-K/A · filed 2012-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |